Larvol Delta - Patient-selfrated-Improvements-with-Opicapone-From-randomized-trials-to-Phase-IV-studies-in-fluctuating-Parkinsons-Disease

Ongentys (opicapone) - Ono Pharmaceutical, Neurocrine Biosciences, BIAL

https://www.mdscongress.org/Abstract-Schedule.pdf

Helena C Brigas

Aug 31, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next